Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
12926
CALL
Invesco S&P 500 Pure Value ETF
RPV
$1.67B
| $27.1K | ﹤0.01% |
300
| – | – |
2024 Q3
1 quarter
|
|
12927
CALL
YieldMax AAPL Option Income Strategy ETF
APLY
$120M
| $27.1K | ﹤0.01% |
+1,500
| New | +$26.9K |
2024 Q4
0 quarters
|
|
|
EPIX
12928
PUT
DELISTED
ESSA Pharma
EPIX
| $27K | ﹤0.01% |
15,100
-5,900
| -28% | -$18.8K |
2022 Q4
8 quarters
|
|
12929
PUT
Future Fuel
FF
$226M
| $27K | ﹤0.01% |
5,100
-1,400
| -22% | -$7.81K |
2022 Q3
9 quarters
|
|
12930
Grupo Cibest SA
CIB
$22.8B
| $27K | ﹤0.01% |
856
-38,693
| -98% | -$1.25M |
2023 Q4
4 quarters
|
|
12931
PUT
Helios Technologies
HLIO
$2.35B
| $26.8K | ﹤0.01% |
600
-1,200
| -67% | -$59.4K |
2024 Q3
1 quarter
|
|
12932
PUT
Clene
CLNN
$55M
| $26.7K | ﹤0.01% |
+5,035
| New | +$25.3K |
2024 Q4
0 quarters
|
|
12933
CALL
iShares Fallen Angels USD Bond ETF
FALN
$1.56B
| $26.7K | ﹤0.01% |
+1,000
| New | +$27K |
2024 Q4
0 quarters
|
|
12934
CALL
Banner Corp
BANR
$2.46B
| $26.7K | ﹤0.01% |
+400
| New | +$27.3K |
2024 Q4
0 quarters
|
|
12935
PUT
Mercantile Bank Corp
MBWM
$1.02B
| $26.7K | ﹤0.01% |
600
+100
| +20% | +$4.65K |
2024 Q1
3 quarters
|
|
12936
CALL
ESCO Technologies
ESE
$6.95B
| $26.6K | ﹤0.01% |
200
| – | – |
2024 Q3
1 quarter
|
|
12937
PUT
Hooker Furnishings Corp
HOFT
$138M
| $26.6K | ﹤0.01% |
+1,900
| New | +$32K |
2024 Q4
0 quarters
|
|
12938
PUT
Black Diamond Therapeutics
BDTX
$103M
| $26.5K | ﹤0.01% |
12,400
-76,000
| -86% | -$218K |
2021 Q1
15 quarters
|
|
12939
PUT
Atlantic Union Bankshares
AUB
$5.45B
| $26.5K | ﹤0.01% |
700
-1,400
| -67% | -$55.5K |
2022 Q4
8 quarters
|
|
12940
Intensity Therapeutics
INTS
$11.6M
| $26.5K | ﹤0.01% |
+599
| New | +$43.5K |
2024 Q4
0 quarters
|
|
12941
CALL
Shenandoah Telecom
SHEN
$637M
| $26.5K | ﹤0.01% |
2,100
-600
| -22% | -$8.07K |
2024 Q2
2 quarters
|
|
12942
CALL
CLPS Inc
CLPS
$29.7M
| $26.4K | ﹤0.01% |
23,000
+18,400
| +400% | +$22.7K |
2023 Q1
7 quarters
|
|
12943
Talphera
TLPH
$57.6M
| $26.4K | ﹤0.01% |
+50,449
| New | +$39.4K |
2024 Q4
0 quarters
|
|
12944
Destination XL Group
DXLG
$21.6M
| $26.3K | ﹤0.01% |
9,783
-54,664
| -85% | -$147K |
2024 Q3
1 quarter
|
|
12945
CALL
Sensus Healthcare
SRTS
$48.9M
| $26.3K | ﹤0.01% |
3,800
+1,700
| +81% | +$12.5K |
2024 Q1
3 quarters
|
|
12946
PUT
Varex Imaging
VREX
$785M
| $26.3K | ﹤0.01% |
1,800
-8,300
| -82% | -$116K |
2023 Q2
6 quarters
|
|
|
AAT
12947
CALL
American Assets Trust
AAT
$1.32B
| $26.3K | ﹤0.01% |
1,000
-6,000
| -86% | -$164K |
2023 Q2
6 quarters
|
|
12948
CALL
Kopin
KOPN
$907M
| $26.2K | ﹤0.01% |
19,300
-33,100
| -63% | -$31.8K |
2020 Q2
18 quarters
|
|
12949
PUT
Exagen
XGN
$198M
| $26.2K | ﹤0.01% |
6,400
+6,000
| +1,500% | +$21.6K |
2023 Q4
4 quarters
|
|
12950
PUT
Fate Therapeutics
FATE
$274M
| $26.2K | ﹤0.01% |
15,900
+6,900
| +77% | +$17.4K |
2019 Q4
20 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.